Icad Inc Stock Investor Sentiment

ICAD Stock  USD 1.54  0.05  3.14%   
About 60% of Icad's investor base is looking to short. The analysis of the overall investor sentiment regarding icad inc suggests that many traders are alarmed. Icad's investor sentiment overview provides quick insight into current market opportunities from investing in icad inc. The current market sentiment, together with Icad's historical and current headlines, can help investors time the market. In addition, many technical investors use icad inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Icad stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Icad daily returns and investor perception about the current price of icad inc as well as its diversification or hedging effects on your existing portfolios.
  

Icad Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Icad can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at finance.yahoo.com         
Icad Reports Q1 Loss, Tops Revenue Estimates
Yahoo News
over six months ago at zacks.com         
Icad Reports Q1 Loss, Tops Revenue Estimates
zacks News
over six months ago at globenewswire.com         
iCAD Reports Financial Results for First Quarter Ended March 31, 2023
Macroaxis News: globenewswire.com
over six months ago at finance.yahoo.com         
New Long-Term Real-World Research Confirms Xoft Skin eBx is as Safe and Effective as Mohs Surgery
Yahoo News
over six months ago at finance.yahoo.com         
iCAD Showcases Breast AI Suite at Society of Breast Imaging Symposium, Worlds Largest Breast Imaging...
Yahoo News
over six months ago at benzinga.com         
iCAD Showcases Breast AI Suite at Society of Breast Imaging Symposium, Worlds Largest Breast Imaging...
benzinga news
over six months ago at finance.yahoo.com         
iCAD to Report First Quarter 2023 Financial Results on May 15, 2023
Yahoo News
over six months ago at news.google.com         
Biopharma relieved as High Court upholds abortion pillfor now - FierceBiotech
Google News at Macroaxis
over six months ago at finance.yahoo.com         
iCADs ProFound Insights, ProFound Impact Webinar Series to Feature Boca Raton Regional Hospital
Yahoo News
over six months ago at news.google.com         
BNP PARIBAS EXANE Upgrades ICADE - Nasdaq
Google News at Macroaxis
over six months ago at finance.yahoo.com         
New and Real-World Clinical Evidence Confirms ProFound AI Increases Cancer Detection without Increas...
Yahoo News
over a year ago at news.google.com         
Non-melanoma Skin Cancer Market size to grow at a CAGR of 5.76 ... - PR Newswire
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Insider Buying iCAD, Inc. Insider Purchases 40,000 Shares of Stock
news
over a year ago at thelincolnianonline.com         
Greenwood Capital Associates LLC Has 603,000 Holdings in iCAD, Inc.
news
over a year ago at thelincolnianonline.com         
Oppenheimer Analysts Increase Earnings Estimates for iCAD, Inc.
news
Far too much social signal, news, headlines, and media speculation about Icad that are available to investors today. That information is available publicly through Icad media outlets and privately through word of mouth or via Icad internal channels. However, regardless of the origin, that massive amount of Icad data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Icad news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Icad relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Icad's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Icad alpha.

Icad Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Insider Trading
02/22/2024
2
iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD,
02/27/2024
3
iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024 Showcases Additional ...
02/28/2024
4
iCAD, Inc. Stock Rockets 26 percent As Investors Are Less Pessimistic Than Expected
02/29/2024
5
Acquisition by Susan Wood of 3879 shares of Icad subject to Rule 16b-3
03/01/2024
6
Is iCAD Inc Stock at the Top of the Medical Devices Industry - InvestorsObserver
03/06/2024
7
iCAD, Inc. Q4 2023 Earnings Call Transcript
03/13/2024
8
iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists
03/19/2024
9
iCAD Share Price Crosses Above 200 Day Moving Average of 1.63 - Defense World
03/28/2024
10
Acquisition by Sassine Andy of 25259 shares of Icad at 1.52 subject to Rule 16b-3
04/01/2024
11
iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries
04/03/2024
12
iCADs ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
04/08/2024
When determining whether icad inc is a strong investment it is important to analyze Icad's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icad's future performance. For an informed investment choice regarding Icad Stock, refer to the following important reports:
Check out Icad Hype Analysis, Icad Correlation and Icad Performance.
Note that the icad inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Complementary Tools for Icad Stock analysis

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.27)
Revenue Per Share
0.676
Quarterly Revenue Growth
0.023
Return On Assets
(0.10)
Return On Equity
(0.21)
The market value of icad inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.